Evidence Hub

Improving Solubility and Dissolution Characteristics of Dapoxetine Hydrochloride through the Liquisolid Compact Method

Nagineni Sudarshan Rao, Ramamohan Vadapalli, Brahmaiah Bonthagarala, Jalluri Charishma Vasavi, Mallabathula Meghana

International Journal of Drug Delivery Technology, 2025

Abstract

This study aimed to enhance the solubility and dissolution properties of Dapoxetine hydrochloride (DXH) tablets by using

of novel method i.e., liquisolid compact technology (LCT). A total of 9 formulations of DXH tablets were prepared by

using carrier materials like microcrystalline cellulose and coating materials like lactose, silica, and starch. In out of nine

formulations Super disintegrants like cross povidone (CP) in F1–F4 and Cross Carmellose Sodium in F5–F9 added. All

formulations were evaluated for both pre compressional and post compressional evaluation parameters. Based on the

evaluation parameters, the F6 formulation exhibited superior dissolution characteristics compared to others, indicating

enhanced solubility rates. In vitro dissolution studies showed significantly improved release rates for DXH tablets.X-ray

diffraction (XRD) analysis revealed a reduction in crystallinity, further supporting enhanced dissolution. Scanning electron

microscopy (SEM) confirmed uniform dispersion of drug particles in the optimized formulation, leading to improved drug

release. The absence of notable interactions between the drug and excipients was confirmed via FTIR analysis, ensuring

formulation stability. In conclusion, LCT effectively enhanced the dissolution rate of DXH, demonstrating its potential as

a promising approach for improving poorly water-soluble drugs.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free